Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1989;227(6):549-61.
doi: 10.1007/BF02169451.

Electroretinography in central retinal vein occlusion. Correlation of electroretinographic changes with pupillary abnormalities

Affiliations
Comparative Study

Electroretinography in central retinal vein occlusion. Correlation of electroretinographic changes with pupillary abnormalities

S S Hayreh et al. Graefes Arch Clin Exp Ophthalmol. 1989.

Abstract

In 149 eyes with central retinal vein occlusion (CRVO), we prospectively investigated the role of routine, clinical electroretinography (ERG) in differentiating ischemic (60 eyes) from nonischemic CRVO (89 eyes). Single-flash photopic and scotopic ERGs were recorded. Data for the amplitudes and implicit times of a- and b-waves and for the b-/a-wave amplitude ratio were analyzed in detail. The study revealed that the best ERG parameter (for both photopic and scotopic ERG) for differentiating ischemic from nonischemic CRVO was a subnormal b-wave amplitude (reduced to less than or equal to 60% or by greater than or equal to 1 SD from the normal mean value, or less than or equal to 64%-69% of that in the fellow normal eye), with a sensitivity of 80%-90% and a specificity of 70%-80%. ERG findings were correlated with the relative afferent pupillary defect (RAPD). An RAPD of greater than or equal to 0.7 log units showed a sensitivity of 88% and a specificity of 90% in differentiating ischemic from nonischemic CRVO. ERG and RAPD findings showed a good correlation. The combined ERG and RAPD tests could differentiate 97%-100% of ischemic from nonischemic CRVO cases, with a specificity of about 70%.

PubMed Disclaimer

References

    1. Arch Ophthalmol. 1987 May;105(5):660-4 - PubMed
    1. Ophthalmologica. 1976;172(1):1-13 - PubMed
    1. Arch Ophthalmol. 1987 Jun;105(6):810-4 - PubMed
    1. Ophthalmology. 1980 Jan;87(1):75-8 - PubMed
    1. Ophthalmology. 1983 May;90(5):488-506 - PubMed

Publication types

MeSH terms

LinkOut - more resources